RNA Therapies Diversify and Become More Impactful
A variety of applications in development promise more potent and accurate attacks on a range of diseases.
Stay updated with breaking news from Replicate Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A variety of applications in development promise more potent and accurate attacks on a range of diseases.
Precision NanoSystems (PNI) will enter into a licensing agreement with Replicate Bioscience to develop self-replicating RNA (srRNA) therapies.
Curia and Replicate Bioscience Enter Strategic Collaboration to Create Groundbreaking Development Platform for Self-Replicating RNA (srRNA)
Middle-East Arab News and Opinion - Asharq Al-Awsat is the world’s premier pan-Arab daily newspaper, printed simultaneously each day on four continents in 14 cities
Kiplinger’s annual roundup of economic good news, technological advances, and medical breakthroughs for you to celebrate on Thanksgiving and throughout the holiday season.